EUVIMEDEUVIMED entdecken
Crossref

Metallomics and Genomics Integration: The Role of ICP-MS and ICP-OES in Genetic Disease Research

S. Likitha, K. Pavan Kumar, N. Pujitha, K. Maneesh Kumar Reddy, C. T. Manjunath, M. Mohan Reddy, P. Mounika, K. Vinod Kumar

International Journal of Drug Delivery Technology · 28.04.2026 · 16 (22s)

DOI: 10.25258/ijddt.16.22s.64 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 28.04.2026. Verfasst von S. Likitha und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic disorders involving metal metabolism dysregulation pose significant challenges in diagnosis, treatment, and monitoring. Traditional diagnostic methods, such as genetic sequencing and biochemical assays, often fail to detect early metabolic imbalances, delaying interventions. Inductively Coupled Plasma (ICP) Spectroscopy, including ICPMass Spectrometry (ICP-MS) and ICP-Optical Emission Spectroscopy (ICP-OES), has emerged as a highly sensitive and precise tool for analyzing trace metal concentrations in biological samples, offering new insights into metalassociated genetic disorders. This article explores the role of ICP spectroscopy in early diagnosis, biomarker discovery, and treatment monitoring for disorders such as Wilson's disease (copper accumulation), hemochromatosis (iron overload), Menkes disease (copper deficiency), and lead poisoning-related neurodevelopmental disorders. ICP-MS enables the detection of ultratrace metal levels, ensuring early intervention before clinical symptoms appear. Additionally, ICP techniques facilitate personalized medicine approaches, allowing for individualized treatment plans based on a patient's metal homeostasis profile. Recent advancements in HR-ICP-MS, single-cell ICP-MS, and laser ablation ICP-MS have further expanded the applications of ICP spectroscopy in genomic and proteomic research, enabling detailed elemental mapping and improved disease modelling. The integration of ICP spectroscopy with omics technologies is paving the way for precision medicine, optimizing treatments for genetic disorders at an individualized level. As ICP technology continues to evolve, it holds immense potential for advancing genetic disorder research, improving diagnostic accuracy, and enhancing therapeutic strategies, ultimately transforming the landscape of metallomics-based medicine.

Zitieren

APA

Likitha, S., Kumar, K. P., Pujitha, N., Reddy, K. M. K., Manjunath, C. T., Reddy, M. M., Mounika, P., & Kumar, K. V. (2026). Metallomics and Genomics Integration: The Role of ICP-MS and ICP-OES in Genetic Disease Research. International Journal of Drug Delivery Technology, 16(22s). https://doi.org/10.25258/ijddt.16.22s.64

Vancouver

Likitha S, Kumar KP, Pujitha N, Reddy KMK, Manjunath CT, Reddy MM, et al. Metallomics and Genomics Integration: The Role of ICP-MS and ICP-OES in Genetic Disease Research. International Journal of Drug Delivery Technology. 2026;16(22s). doi:10.25258/ijddt.16.22s.64

BibTeX
@article{Likitha2026,
  author = {Likitha, S. and Kumar, K. Pavan and Pujitha, N. and Reddy, K. Maneesh Kumar and Manjunath, C. T. and Reddy, M. Mohan and Mounika, P. and Kumar, K. Vinod},
  title = {Metallomics and Genomics Integration: The Role of ICP-MS and ICP-OES in Genetic Disease Research},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {22s},
  doi = {10.25258/ijddt.16.22s.64}
}
Kostenlos starten →